Mone Zaidi
#138,259
Most Influential Person Now
Endocrinology researcher
Mone Zaidi's AcademicInfluence.com Rankings
Mone Zaidibiology Degrees
Biology
#9617
World Rank
#12841
Historical Rank
Endocrinology
#123
World Rank
#134
Historical Rank
Download Badge
Biology
Mone Zaidi's Degrees
- Masters Biology Stanford University
Similar Degrees You Can Earn
Why Is Mone Zaidi Influential?
(Suggest an Edit or Addition)Mone Zaidi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Skeletal remodeling in health and disease (2007) (920)
- Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (2009) (802)
- TSH Is a Negative Regulator of Skeletal Remodeling (2003) (609)
- FSH Directly Regulates Bone Mass (2006) (606)
- Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter‐organelle crosstalk (1999) (368)
- The myokine irisin increases cortical bone mass (2015) (338)
- Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. (1991) (326)
- Genotype–phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency (2013) (247)
- Oxytocin is an anabolic bone hormone (2009) (222)
- Molecular regulation of mechanotransduction. (2005) (220)
- Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. (2007) (218)
- Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. (2003) (217)
- 'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation. (1989) (215)
- Blocking FSH induces thermogenic adipose tissue and reduces body fat (2017) (213)
- Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage (2010) (209)
- Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. (2014) (208)
- Stimulation of osteoclastic bone resorption by hydrogen peroxide. (1992) (206)
- MEDULLARY BONE AND AVIAN CALCIUM REGULATION (1993) (193)
- Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation (2006) (190)
- Osteoclastogenesis, Bone Resorption, and Osteoclast‐Based Therapeutics (2003) (182)
- Peptides from the calcitonin genes: molecular genetics, structure and function. (1988) (176)
- A new function for CD38/ADP-ribosyl cyclase in nuclear Ca2+ homeostasis (1999) (167)
- Mitochondria to nucleus stress signaling (2003) (166)
- BMP-12 Treatment of Adult Mesenchymal Stem Cells In Vitro Augments Tendon-Like Tissue Formation and Defect Repair In Vivo (2011) (163)
- Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. (2008) (162)
- Mechanisms balancing skeletal matrix synthesis and degradation. (2002) (156)
- Osteoclast signalling pathways. (2005) (156)
- Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways. (1990) (154)
- Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS. (2002) (148)
- A ryanodine receptor-like molecule expressed in the osteoclast plasma membrane functions in extracellular Ca2+ sensing. (1995) (133)
- ACTH protects against glucocorticoid-induced osteonecrosis of bone (2010) (130)
- Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption. (1992) (128)
- Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis (2012) (124)
- Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss (2008) (123)
- Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption. (1990) (120)
- Circulating CGRP comes from the perivascular nerves. (1985) (120)
- Calcineurin regulates bone formation by the osteoblast. (2005) (119)
- Biology of peptides from the calcitonin genes. (1987) (113)
- Structure–phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia (2013) (113)
- In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. (1989) (113)
- Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia (2013) (110)
- FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. (2010) (108)
- TNFα mediates the skeletal effects of thyroid-stimulating hormone (2006) (106)
- Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes (2013) (103)
- Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts (1993) (102)
- Induction of a program gene expression during osteoblast differentiation with strontium ranelate. (2007) (102)
- Role of mitochondrial reactive oxygen species in osteoclast differentiation (2010) (101)
- Disorders Associated With Acute Rapid and Severe Bone Loss (2003) (100)
- Inhibition of osteoclastic acid phosphatase abolishes bone resorption. (1989) (96)
- Emerging Insights into the Role of Calcium Ions in Osteoclast Regulation (1999) (94)
- Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease (2014) (92)
- A direct action of human calcitonin gene-related peptide on isolated osteoclasts. (1987) (92)
- The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. (2009) (92)
- Mode of Action of Interleukin-6 on Mature Osteoclasts. Novel Interactions with Extracellular Ca2+ Sensing in the Regulation of Osteoclastic Bone Resorption (1998) (90)
- Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. (2012) (89)
- Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: Further evidence for a “calcium receptor” (1991) (89)
- Effects of peptides from the calcitonin genes on bone and bone cells. (1988) (88)
- Calcitonin and bone formation: a knockout full of surprises. (2002) (85)
- Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency (2017) (84)
- Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. (2010) (82)
- Physiological loading of joints prevents cartilage degradation through CITED2 (2011) (80)
- Cd38/Adp-Ribosyl Cyclase: A New Role in the Regulation of Osteoclastic Bone Resorption (1999) (79)
- The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts (1989) (78)
- ACTH is a novel regulator of bone mass (2010) (77)
- Role of the endothelial cell in osteoclast control: new perspectives. (1993) (77)
- The calcitonin gene peptides: biology and clinical relevance. (1990) (77)
- Osteoclastic differentiation and function regulated by old and new pathways (2007) (76)
- Cathepsin K, Osteoclastic Resorption, and Osteoporosis Therapy (2001) (75)
- Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton* (2012) (73)
- Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis (2013) (73)
- Regulation of cytosolic free calcium in isolated rat osteoclasts by calcitonin. (1992) (72)
- Disordered osteoclast formation and function in a CD38 (ADP‐ribosyl cyclase)‐deficient mouse establishes an essential role for CD38 in bone resorption (2003) (70)
- The origin of circulating calcitonin gene-related peptide in the rat. (1986) (70)
- Gaucher disease gene GBA functions in immune regulation (2012) (70)
- Evidence for release of calcitonin gene-related peptide and neurokinin a from sensory nerve endings in vivo (1988) (69)
- TSH and Bone Loss (2006) (68)
- A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+ signaling via CD38/ADP‐ribosyl cyclase, a putative intracellular NAD+ sensor (2002) (68)
- Minireview: The link between fat and bone: does mass beget mass? (2012) (66)
- Calcium signalling and calcium transport in bone disease. (2007) (66)
- Amylin‐amide: a new bone‐conserving peptide from the pancreas (1990) (65)
- TNF regulates cellular NAD+ metabolism in primary macrophages. (2006) (65)
- Bone, Inflammation, and Inflammatory Bowel Disease (2011) (65)
- Further studies on the mode of action of calcitonin on isolated rat osteoclasts: pharmacological evidence for a second site mediating intracellular Ca2+ mobilization and cell retraction. (1993) (64)
- Extracellular Ca2+ sensing by the osteoclast. (1993) (62)
- The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis. (2011) (62)
- Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures (2011) (61)
- Calcitonin gene-related peptide inhibits osteoclastic bone resorption: A comparative study (1987) (60)
- CELLULAR BIOLOGY OF BONE RESORPTION (1993) (59)
- Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor (2014) (58)
- Bisphosphonates inactivate human EGFRs to exert antitumor actions (2014) (58)
- Modularity of osteoclast behaviour and “mode-specific” inhibition of osteoclast function (1990) (58)
- Emergency department visits after use of a drug sold as "bath salts"--Michigan, November 13, 2010-March 31, 2011. (2011) (56)
- The Central Nervous System (CNS)-independent Anti-bone-resorptive Activity of Muscle Contraction and the Underlying Molecular and Cellular Signatures* (2013) (55)
- Epitope-specific monoclonal antibodies to FSHβ increase bone mass (2018) (53)
- Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts. (2011) (53)
- Blocking FSH action attenuates osteoclastogenesis. (2012) (53)
- Regulation of Skeletal Homeostasis. (2018) (53)
- Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. (2007) (52)
- Male Osteoporosis: Epidemiology and the Pathogenesis of Aging Bones (2011) (52)
- Osteoclast function and its control (1993) (50)
- “Calcium receptors” on eukaryotic cells with special reference to the osteoclast (1990) (50)
- New insights into the regulation of cathepsin K gene expression by osteoprotegerin ligand. (2001) (49)
- Amylin and amylin-amide lack an acute effect on blood glucose and insulin. (1990) (49)
- Activation of the Ca2+ “receptor” on the osteoclast by Ni2+ elicits cytosolic Ca2+ signals: Evidence for receptor activation and inactivation, intracellular Ca2+ redistribution, and divalent cation modulation (1993) (48)
- Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss (2009) (48)
- Molecular and Functional Evidence for Calcineurin-A α and β Isoforms in the Osteoclast: Novel Insights into Cyclosporin A Action on Bone Resorption (1999) (48)
- TNFalpha mediates the skeletal effects of thyroid-stimulating hormone. (2006) (48)
- Calcium sensing and cell signaling processes in the local regulation of osteoclastic bone resorption (2004) (48)
- Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer (2014) (48)
- Functions of vasopressin and oxytocin in bone mass regulation (2015) (47)
- Selective antagonism of calcitonin-induced osteoclastic quiescence (Q effect) by human calcitonin gene-related peptide-(Val8Phe37). (1991) (47)
- Calcium and bone disease. (2011) (47)
- Islet amyloid polypeptide: production by an osteoblast cell line and possible role as a paracrine regulator of osteoclast function in man. (1991) (46)
- NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP (2005) (46)
- Further evidence for direct pro-resorptive actions of FSH. (2010) (46)
- FSH blockade improves cognition in mice with Alzheimer’s disease (2022) (46)
- Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning (2019) (45)
- Anabolic steroids reduce spinal cord injury-related bone loss in rats associated with increased Wnt signaling (2013) (45)
- The Oxytocin–Bone Axis (2014) (45)
- Thyroid and bone: macrophage-derived TSH-β splice variant increases murine osteoblastogenesis. (2013) (44)
- Anabolic actions of Notch on mature bone (2016) (44)
- Calcitonin: the other thyroid hormone. (2002) (44)
- Ca(2+) influx through the osteoclastic plasma membrane ryanodine receptor. (2002) (44)
- Novel biochemical and functional insights into nuclear Ca(2+) transport through IP(3)Rs and RyRs in osteoblasts. (2000) (42)
- Structure-activity relationship of human calcitonin-gene-related peptide. (1990) (41)
- FSH, Bone Mass, Body Fat, and Biological Aging. (2018) (41)
- Intracellular calcium in the control of osteoclast function. II. Paradoxical elevation of cytosolic free calcium by verapamil. (1990) (40)
- Oxytocin deficiency impairs maternal skeletal remodeling. (2009) (40)
- Actions of pituitary hormones beyond traditional targets. (2018) (38)
- Is the osteoclast calcium "receptor" a receptor-operated calcium channel? (1992) (38)
- Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts (1998) (37)
- Thyroid-stimulating hormone, thyroid hormones, and bone loss (2009) (36)
- The osteoclast Ca2+ receptor is highly sensitive to activation by transition metal cations. (1992) (36)
- Translational musculoskeletal science: Is sarcopenia the next clinical target after osteoporosis? (2011) (35)
- Novel mechanisms of calcium handling by the osteoclast: A review-hypothesis. (1999) (35)
- Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency (2017) (34)
- Genetic confirmation for a central role for TNFα in the direct action of thyroid stimulating hormone on the skeleton (2013) (34)
- Coupling bone degradation to formation (2009) (34)
- Evidence that a ryanodine receptor triggers signal transduction in the osteoclast. (1992) (34)
- Proresorptive Actions of FSH and Bone Loss (2007) (34)
- Emerging concepts in the epidemiology, pathophysiology, and clinical care of osteoporosis across the menopausal transition. (2018) (34)
- Linkage of extracellular and intracellular control of cytosolic Ca2+ in rat osteoclasts in the presence of thapsigargin (1993) (33)
- FSH Beyond Fertility (2019) (33)
- TNF-induced gene expression oscillates in time. (2008) (32)
- Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice. (2005) (32)
- Transient appearance of calcitonin gene-related peptide-like immunoreactive fibers in the developing cerebellum of the rat (1987) (32)
- Calcitonin and the peptides from the calcitonin gene. (1987) (32)
- Nandrolone slows hindlimb bone loss in a rat model of bone loss due to denervation (2010) (32)
- Regulation of bone turnover by calcium‐regulated calcium channels (2010) (31)
- Calcitonin: Physiological Actions and Clinical Applications (2004) (31)
- A quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationships with cellular function (2004) (31)
- MicroRNA 874-3p Exerts Skeletal Anabolic Effects Epigenetically during Weaning by Suppressing Hdac1 Expression* (2015) (31)
- Caffeine modulates Ca2+ receptor activation in isolated rat osteoclasts and induces intracellular Ca2+ release. (1995) (31)
- Molecular physiology and pharmacology of calcitonin. (2006) (31)
- Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells. (2010) (30)
- Cyclosporine and cremaphor modulate von Willebrand factor release from cultured human endothelial cells. (1993) (30)
- Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts. (2002) (30)
- The effect of extracellularly applied divalent cations on cytosolic Ca2+ in murine Leydig cells: evidence for a Ca2+‐sensing receptor (1998) (29)
- Oxytocin and bone. (2014) (29)
- Amylin in bone conservation current evidence and hypothetical Considerations (1993) (29)
- The Developmental Basis of Skeletal Cell Differentiation and the Molecular Basis of Major Skeletal Defects (2008) (29)
- Intracellular calcium in the control of osteoclast function. I. Voltage-insensitivity and lack of effects of nifedipine, BAYK8644 and diltiazem. (1990) (29)
- Bone Loss in Thyroid Disease (2007) (28)
- Identification and characterization of a sodium/calcium exchanger, NCX-1, in osteoclasts and its role in bone resorption. (2001) (27)
- Expression and function of the calcitonin gene products. (1991) (27)
- Skeletal receptors for steroid‐family regulating glycoprotein hormones (2011) (27)
- Functional grouping of osteoclast genes revealed through microarray analysis. (2008) (27)
- Regulation of extracellular calcium sensing in rat osteoclasts by femtomolar calcitonin concentrations. (1996) (27)
- Functional and molecular evidence for P2X receptors in LLC-PK1 cells. (1998) (27)
- Selective upregulation of the ADP-ribosyl cyclases CD38 and CD157 by TNF but not by RANK-L reveals differences in downstream signaling. (2006) (26)
- Extracellularly applied ruthenium red and cADP ribose elevate cytosolic Ca2+ in isolated rat osteoclasts. (1996) (26)
- Vitamin C Prevents Hypogonadal Bone Loss (2012) (25)
- Training the physician-scientist: views from program directors and aspiring young investigators. (2018) (25)
- Structure and functional regulation of the CD38 promoter. (2006) (25)
- Expanding the Role of Thyroid-Stimulating Hormone in Skeletal Physiology (2017) (25)
- Osteoporosis: trends and intervention. (2002) (25)
- Dimensional analysis of osteoclastic bone resorption and the measurement of biologically active calcitonin (1994) (24)
- Identification of CITED2 as a negative regulator of fracture healing. (2009) (24)
- Oxytocin regulates body composition (2019) (24)
- FSIP1 regulates autophagy in breast cancer (2018) (24)
- Understanding estrogen action during menopause. (2009) (24)
- Oxidative stress and its control: a pathogenetic role in inflammatory joint disease. (1993) (23)
- Effect of membrane potential on surface Ca2+ receptor activation in rat osteoclasts (1995) (23)
- T3 Regulates a Human Macrophage-Derived TSH-β Splice Variant: Implications for Human Bone Biology. (2016) (23)
- HIV and Bone Loss (2010) (23)
- Correlates of osteoclast function in the presence of perchlorate ions in the rat (1991) (23)
- FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness (2017) (23)
- Calcitonin gene-related peptide: a review of its biology and relevance to the cardiovascular system. (1989) (23)
- The Role of FSH and TSH in Bone Loss and Its Clinical Relevance (2010) (23)
- Evaluating the antifracture efficacy of bisphosphonates. (2009) (22)
- A possible new role for vitamin D-binding protein in osteoclast control: inhibition of extracellular Ca2+ sensing at low physiological concentrations. (1998) (22)
- Low TSH triggers bone loss: fact or fiction? (2006) (22)
- A dual effect of calcitonin gene-related peptide on plasma calcium levels in the chick. (1990) (22)
- First-in-class humanized FSH blocking antibody targets bone and fat (2020) (21)
- Neural surveillance of skeletal homeostasis. (2005) (21)
- Questioning the association between bisphosphonates and atypical femoral fractures (2015) (21)
- Intravenous Ibandronate Acutely Reduces Bone Hyperresorption in Chronic Critical Illness (2012) (21)
- Macrophage colony-stimulating factor suppresses osteoblast formation. (2001) (21)
- Activation and inactivation of the osteoclast Ca2+ receptor by the trivalent cation, La3+. (1992) (20)
- Direct microsensor measurement of nitric oxide production by the osteoclast. (1999) (20)
- Stimulation of a Gs-like G protein in the osteoclast inhibits bone resorption but enhances tartrate-resistant acid phosphatase secretion. (1993) (20)
- Further evidence for the origin of circulating calcitonin gene‐related peptide in the rat. (1989) (20)
- Further evidence that FSH causes bone loss independently of low estrogen (2012) (20)
- Chapter 15 - Free radical pathways in the inflammatory response (1994) (19)
- The “Love Hormone” Oxytocin Regulates the Loss and Gain of the Fat–Bone Relationship (2015) (19)
- Implementing a "publish, then review" model of publishing (2020) (18)
- Serum FSH Is Associated with BMD, Bone Marrow Adiposity and Body Composition in the AGES-Reykjavik Study of Older Adults. (2020) (18)
- Tetracyclines modulate cytosolic Ca2+ responses in the osteoclast associated with “Ca2+ receptor” activation (1993) (18)
- Transforming growth factor-β-induced mitogenesis of human bone cancer cells (1989) (18)
- Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption. (1999) (17)
- Extracellular cation sensing by the enterocyte: prediction of a novel divalent cation "receptor". (1995) (17)
- Extracellular NAD+ metabolism modulates osteoclastogenesis. (2006) (17)
- Voltage sensitivity of the osteoclast calcium receptor. (1993) (17)
- Functional consequences of the interaction of Ni2+ with the osteoclast Ca2+ ‘receptor’ (1993) (17)
- Tuberculosis as primary renal diagnosis in end-stage uremia (1994) (16)
- The effect of tetracyclines on quantitative measures of osteoclast morphology (1993) (16)
- Modulation of the osteoclast Ca2+ receptor by extracellular protons: possible linkage between Ca2+ sensing and extracellular acidification. (1994) (16)
- From the gut to the strut: where inflammation reigns, bone abstains. (2016) (16)
- The crossover of bisphosphonates to cancer therapy (2010) (16)
- Role of the pituitary-bone axis in skeletal pathophysiology (2009) (16)
- Molecular and Clinical Pharmacology of Calcitonin (2002) (15)
- The origin of circulating calcitonin gene-related peptide (1986) (15)
- Commentary-FSH and bone 2010: evolving evidence. (2010) (15)
- Functional and molecular evidence for P2X receptors in LLC-PK1 cells. (1998) (15)
- Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass (2020) (15)
- Pituitary-bone connection in skeletal regulation (2016) (15)
- FSH-Metabolic Circuitry and Menopause. (2019) (15)
- Denosumab for the Treatment of Osteoporosis (2010) (15)
- INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS. (2016) (14)
- The NO–cGMP–PKG pathway in skeletal remodeling (2020) (14)
- A highly specific and sensitive enzyme-immunometric assay for calcitonin gene-related peptide based on enzyme amplification. (1988) (14)
- A new approach for calcitonin determination based on target cell responsiveness (1990) (14)
- Production and characterisation of immunoreactive calcitonin gene-related peptide (CGRP) from a CGRP receptor-positive cloned osteosarcoma cell line (UMR 106.01). (1989) (14)
- Molecular cloning, expression, and function of osteoclastic calcineurin Aα (2003) (14)
- IP3, IP3 receptor, and cellular senescence (2000) (13)
- Opening windows for bone remodeling through a SLIT (2018) (13)
- MOLECULAR MECHANISMS OF CALCITONIN ACTION (1994) (13)
- Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine. (2018) (13)
- Translational medicine: Double protection for weakened bones (2012) (13)
- New insights: Elevated follicle-stimulating hormone and bone loss during the menopausal transition (2009) (12)
- A hypothesis for the local control of osteoclast function by Ca2+, nitric oxide and free radicals (1992) (12)
- Skeletal biology and medicine (2010) (12)
- Osteoclasts from medullary bone of egg‐laying Japanese quail do not express the putative calcium ‘receptor’ (1992) (12)
- Development and performance of a highly sensitive carboxyl-terminal-specific radioimmunoassay of calcitonin gene-related peptide. (1988) (12)
- Molecular cloning, expression, and functional characterization of a novel member of the CD38 family of ADP-ribosyl cyclases. (2000) (12)
- TNF-induced oscillations in combinatorial transcription factor binding. (2008) (12)
- Kidney: a target organ for calcitonin gene‐related peptide (1990) (12)
- CD38 is required for priming by TNF-α: a mechanism for extracellular coordination of cell fate (2007) (12)
- Response: Both FSH and Sex Steroids Influence Bone Mass (2006) (12)
- Disease-drug pairs revealed by computational genomic connectivity mapping on GBA1 deficient, Gaucher disease mice (2012) (11)
- Effect of raised extracellular calcium on cell spread area in quail medullary bone osteoclasts (1994) (11)
- Single pulses of cytoplasmic calcium associated with phagocytosis of individual zymosan particles by macrophages. (1991) (11)
- Contemporaneous reproduction of preclinical science: a case study of FSH and fat (2017) (11)
- A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype–phenotype nonconcordance (2016) (11)
- Molecular and cellular biology of bone (1998) (10)
- TNF-induced MAP kinase activation oscillates in time. (2008) (10)
- Enhanced osteoclastogenesis by mitochondrial retrograde signaling through transcriptional activation of the cathepsin K gene (2016) (10)
- Complexity in signal transduction (2010) (10)
- Uncoupling of receptor-mediated cellular responses by ionic lithium. (1989) (10)
- Special stem cells for bone. (2012) (10)
- Cellular and Molecular Consequences of Calcineurin Aα Gene Deletion (2007) (10)
- Modeling of Serum C‐Telopeptide Levels with Daily and Monthly Oral Ibandronate in Humans (2006) (9)
- The high-density lipoprotein receptor Scarb1 is required for normal bone differentiation in vivo and in vitro (2019) (9)
- Cytosolic free calcium measurements in single cells using calcium-sensitive fluorochromes. (1994) (9)
- Calcium influx and release in isolated rat osteoclasts (1994) (9)
- Skeletal development and remodeling in health, disease, and aging (2006) (9)
- Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia. (2016) (9)
- Clinical, cellular and molecular phenotypes of aging bone. (2010) (9)
- Quantitative studies on the effect of prostacyclin on freshly isolated rat osteoclasts in culture. (1994) (9)
- Regulation of FSH receptor promoter activation in the osteoclast. (2007) (9)
- Enhanced circulating levels of neurally derived calcitonin gene related peptide in spontaneously hypertensive rats. (1991) (9)
- Receptor becomes a ligand to control bone remodelling (2018) (8)
- Understanding osteoclast formation and function: implications for future therapies for osteoporosis (2003) (8)
- CD38 is required for priming by TNF-alpha: a mechanism for extracellular coordination of cell fate. (2007) (8)
- Closing the loop on the bone-resorbing osteoclast (2016) (8)
- Cytochrome c oxidase dysfunction enhances phagocytic function and osteoclast formation in macrophages (2019) (8)
- Ca2+ channels in human term trophoblast cells in vitro. A study using the Ca2+-sensitive dye fura 2 (1994) (8)
- Calcitonin gene-related peptide: endocrine distribution and characterization of circulating forms (1989) (7)
- Upregulation of functional ryanodine receptors during in vitro aging of human diploid fibroblasts. (1998) (7)
- Restoration of Bone Mass in Hpg Mouse by Preoptic Area Grafting (2006) (7)
- A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred (2016) (7)
- Skeletal morphofunctional considerations and the pituitary-thyroid axis. (2009) (6)
- Voltage‐sensitive elevation of cytosolic [Ca2+] in guinea‐pig cardiac myocytes elicited by calcitonin gene‐related peptide (1992) (6)
- Progression of Efficacy with Ibandronate (2007) (6)
- Iain MacIntyre 1924–2008 (2009) (6)
- Peer review without gatekeeping (2022) (6)
- The Hepcidin Regulator Erythroferrone is a New Member of the Erythropoiesis–Iron–Bone Circuitry (2021) (6)
- Similarities and Contrasts in Ryanodine Receptor Localization and Function in Osteoclasts and Striated Muscle Cells (2007) (6)
- Adrenergic stimulation decreases osteoblast oxytocin synthesis (2011) (6)
- Descriptive analysis of concomitant prescription medication patterns from 1999 to 2004 among US women receiving daily or weekly oral bisphosphonate therapy. (2008) (5)
- Anti-Cancer Actions of Denosumab (2011) (5)
- In Memoriam: The Life and Works of Itai Bab (1945–2014) (2015) (5)
- Follicle-stimulating hormone level and changes in bone mass and body composition in older women and men. (2021) (5)
- The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry (2021) (5)
- IP(3), IP(3) receptor, and cellular senescence. (2000) (5)
- TSH, Hyperthyroidism, and Bone Mass. (2021) (5)
- Production of calcitonin gene-related peptide from human cancer cells. (1989) (5)
- The role of PDGF-BB in the bone-vascular relationship during aging. (2021) (4)
- Development and performance of a highly sensitive and specific two-site immunometric assay of calcitonin gene-related peptide. (1990) (4)
- AMYLIN : A NEW CALCIUM-REGULATING HORMONE FROM THE PANCREAS ? (1991) (4)
- Cell biology: Tumour stem cells in bone (2013) (4)
- Transforming growth factor-beta-induced mitogenesis of human bone cancer cells. (1989) (4)
- Cellular and molecular consequences of calcineurin A alpha gene deletion. (2007) (4)
- Calcitonin and the peptides from the calcitonin gene (1987) (4)
- Hormonal Control of Extracellular Calcium (1988) (3)
- Characterisation of the osteoclast calcium “receptor”: evidence for a novel receptor-operated calcium channel and intracellular mobilisation (1992) (3)
- Reverse cholesterol transport and hepatic osteodystrophy. (2022) (3)
- The Pituitary‐Bone Connection (2013) (3)
- Perchlorate: a powerful inhibitor of bone resorption. (1990) (3)
- Safety of Intravenous Ibandronate Injections in Postmenopausal Osteoporosis: DIVA 2-Year Findings (2006) (3)
- Biological activity of calcitonin and its assessment (1990) (3)
- Chapter 28 - Genetics and Cell Biology of Calcitonin Action (1997) (3)
- Erythroferrone Regulates Bone Remodeling in β-Thalassemia. (2019) (3)
- Cell signaling (2010) (3)
- MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass (2021) (3)
- The Cellular and Molecular Aspects of Immunosuppressant Osteoporosis (2003) (2)
- Paradigm shift in the pathophysiology of postmenopausal and thyrotoxic osteoporosis. (2009) (2)
- Independent Skeletal Actions of Pituitary Hormones (2022) (2)
- Molecular Effects of Calcineurin Inhibitors (2005) (2)
- FSH-blocking therapeutic for osteoporosis (2022) (2)
- New horizons in skeletal physiology and pathophysiology. (2010) (2)
- Beyond Reproduction: Pituitary Hormone Actions on Bone. (2016) (2)
- EP receptor agonists and other osteogenic therapies for bone repair (2007) (2)
- A global view of the aspiring physician-scientist (2022) (2)
- Pharmacological and Biological Therapies for Metabolic Bone Disease in Critical Illness: An Integrative Physiology Approach (2010) (2)
- Bone resorption goes green (2021) (2)
- A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca 2 (cid:1) signaling via CD38/ADP-ribosyl cyclase, a putative intracellular NAD (cid:1) sensor (2002) (2)
- Molecules, mechanisms, and momentum in bone and cartilage research. (2005) (2)
- Skeletal Fragility in the Elderly (2003) (2)
- Aspects of bone morphogenesis and remodeling (2007) (1)
- The Human TSHβ Subunit Proteins and their Binding Sites on the TSH Receptor Using Molecular Dynamics Simulation. (2020) (1)
- osteoblast and osteoclast formation Follicle-stimulating hormone stimulates TNF production from immune cells to enhance (2006) (1)
- Beta calcitonin gene-related peptide lowers plasma calcium and inhibits osteoclastic bone resorption (1986) (1)
- The Molecular Pharmacology of Osteoporosis (2003) (1)
- Pituitary Hormone-Driven Mechanism for Skeletal Loss (2017) (1)
- Rigorous review and editorial oversight of clinical preprints (2021) (1)
- Getting Warmer: Following One's Gut to Build Bone. (2020) (1)
- Cd38/Adp-Ribosyl Cyclase (1999) (1)
- Direct actions of pituitary hormones on bone (2005) (1)
- Calcium Handling by the Osteoclast (2000) (1)
- Faculty Opinions recommendation of Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. (2008) (1)
- Structureactivity relationship of human calcitonin-gene-related peptide (2005) (1)
- TSH and Thyroid Hormones Both Regulate Bone Mass (2008) (1)
- Reply to Graham et al.: In silico atomistic coordinates and molecular dynamics simulation trajectories of the glucocerebrosidase–saposin C complex (2019) (1)
- Introduction to Molecular and Integrative Physiology of the Musculoskeletal System (2010) (1)
- Drug Repurposing by Connectivity Mapping and Structural Modeling (2019) (1)
- Two underlying diseases causing hypercalcaemia? (2002) (1)
- Endothelial cells revealed as chondroclasts (2019) (1)
- Correction: The high-density lipoprotein receptor Scarb1 is required for normal bone differentiation in vivo and in vitro (2019) (1)
- FSH and Bone 2010: Evolving Evidence (2010) (1)
- Molecular Pharmacology of Antiresorptive Therapy for Osteoporosis (1998) (1)
- Observations on Ca2+ entry into cultured human term trophoblasts via a putative Ca2+-operated Ca2+ channel (1992) (1)
- GBA1 deficient mice recapitulates Gaucher disease displaying system-wide cellular and molecular dysregulation beyond the macrophage (2011) (1)
- Author response: The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry (2021) (0)
- Comprar Skeletal Biology and Medicine, Part B | MONE ZAIDI | 9781573317283 | Blackwell Publishing (2008) (0)
- Posttransplant Bone Loss (2020) (0)
- FSH, Body Fat, Bone Mass and Biological Aging (2018) (0)
- Misdiagnosis of Atypical Femur Fractures (2015) (0)
- A Single Multipurpose FSH–Blocking Therapeutic for Osteoporosis and Obesity (2022) (0)
- Islet Amyloid Polypeptide: A Paracrine Regulator of Bone Metabolism? (1991) (0)
- Participation in Health Services/Population Health Research in U.S. Departments of Medicine. (2020) (0)
- Rare Presentation of Severe Pediatric Rickets (2022) (0)
- Osteomalacia: A Cause of Bisphosphonate Failure (2008) (0)
- Receptor becomes a ligand to control bone remodelling (2018) (0)
- Brain atlas for glycoprotein hormone receptors at single-transcript level (2022) (0)
- Erratum: Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia (Proceedings of the National Academy of Sciences of the United States of America (2013) 110 (18644-18649) DOI: 10.1073/pnas.1318257110) (2014) (0)
- Faculty Opinions recommendation of Population-level transcription cycles derive from stochastic timing of single-cell transcription. (2010) (0)
- Introduction (2010) (0)
- New Insights into Diagnosing Bone Diseases (2022) (0)
- Abstract #310: Modeling of Serum CTX Levels with Daily and Monthly Oral Ibandronate (2006) (0)
- Preface (2020) (0)
- Editor's evaluation: Microtubules regulate pancreatic β-cell heterogeneity via spatiotemporal control of insulin secretion hot spots (2020) (0)
- CHAPTER 7 – Osteoclast Biology (2008) (0)
- Faculty Opinions recommendation of Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. (2007) (0)
- Regulation of Bone Mass and Body Composition by Anterior Pituitary Hormones (2020) (0)
- Oxytocin and Bone 1 2 (2014) (0)
- Direct or oxytocin - mediated estrogen actions on bone (2010) (0)
- Faculty Opinions recommendation of Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. (2009) (0)
- Skeletal effects of Oxytocin and Vasopressin (2018) (0)
- Endothelial cells revealed as chondroclasts (2019) (0)
- Pituitary Hormones and the Pathophysiology of Osteoporosis (2012) (0)
- Delayed Diagnosis of Osteoporosis (2015) (0)
- Osteoporosis Due to Hormonal Withdrawal: Common Mistakes (2008) (0)
- Metabolic Bone Disease Following Organ Transplantation (2015) (0)
- Molecular cloning, expression, and function of osteoclastic calcineurin Aalpha. (2003) (0)
- SAT-558 Tsh Modulation Of Bone Biology - Further Evidence From A Recombinant Tsh-β Variant. (2019) (0)
- Functional and molecular evidence for P 2 X receptors in LLC-PK 1 cells (1998) (0)
- Optimizing a therapeutic humanized follicle‐stimulating hormone–blocking antibody formulation by protein thermal shift assay (2023) (0)
- Unusual Manifestations of Paget’s Disease of Bone (2008) (0)
- Faculty Opinions recommendation of Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs. (2020) (0)
- The Second Conference on Skeletal Medicine and Biology: Special Features (2007) (0)
- Faculty Opinions recommendation of Coupling of bone resorption and formation by RANKL reverse signalling. (2018) (0)
- Faculty Opinions recommendation of Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. (2007) (0)
- Faculty Opinions recommendation of Adipose TSHB in humans and serum TSH in hypothyroid rats inform about cellular senescence. (2019) (0)
- Faculty Opinions recommendation of Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. (2021) (0)
- Multiple Risk Factors for Osteoporosis and Fracture (2015) (0)
- The Second Conference on Skeletal Medicine and Biology (2007) (0)
- Bone circuitry and interorgan skeletal crosstalk (2023) (0)
- Beyond bone biology: Lessons from team science (2020) (0)
- An Update on Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-free Foetal DNA in Maternal Plasma (2015) (0)
- Solid Organ Transplantation, Chronic Renal Impairment, and Skeletal Complications (2008) (0)
- The pituitary-bone axis. (2011) (0)
- RF10 | PMON205 LH/CG Receptor Activation Protects Mice from Diet-Induced Obesity and Modifies Adipose Tissue Immune Response (2022) (0)
- Editorial: Skeletal Biology and Skeletal Medicine (2006) (0)
- The Skeleton and Its Integration with Other Tissues (2013) (0)
- Faculty Opinions recommendation of Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes. (2021) (0)
- Integrative Physiology of the Skeleton (2018) (0)
- Lack of oxytocin retards osteoblast differentiation and bone formation (2008) (0)
- Introduction: The New York Skeletal Biology and Medicine Conferences (2010) (0)
- Elevated cytosolic calcium levels in human lymphocytes during surface virus infections (1994) (0)
- Leong Physiological Loading of Joints FASEB J 2011 (2013) (0)
- Evidence for a purinergic P2 -like receptor in cultured human trophoblast cells (1992) (0)
- Contributors (2019) (0)
- Metabolic Bone Disease and Osteoporosis (2021) (0)
- Convergence Research Unmasks Drug Targets Beyond Bone (2019) (0)
- The Life and Works of Solomon Epstein, MD, FRCP (1940–2020) (2020) (0)
- Faculty Opinions recommendation of Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. (2008) (0)
- PMON51 A Single Multipurpose FSH–Blocking Therapeutic for Osteoporosis, Obesity and Alzheimer's Disease (2022) (0)
- The Use of Annual Cumulative Exposure to Evaluate the Efficacy of Ibandronate (2008) (0)
- Editorial (2006) (0)
- Two underlying diseases causing hypercalcaemia? Authors' reply (2002) (0)
- Biology of Calcitonin as An Osteoprotective Agent (2020) (0)
- Faculty Opinions recommendation of Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort. (2014) (0)
- Disease mechanisms and therapeutic challenges (2007) (0)
- Oxytocin: An estrogen-controlled autocrine-paracrine modulator of osteoclastogenesis and bone resorption (2006) (0)
- The myokine Irisin improves bone quality and strength (2016) (0)
- Cathepsin K and Bone Resorption (2020) (0)
- The Pituitary–Bone Axis in Health and Disease (2018) (0)
- bone-resorbing osteoclasts Evidence that calcineurin is required for the genesis of (2016) (0)
- Extracellular Calcium Ion Sensing in Osteoclasts (1998) (0)
- Faculty Opinions recommendation of Gestational Weight Gain in Women with Polycystic Ovary Syndrome: A Controlled Study. (2018) (0)
- Therapy of osteoporosis : cell biology, clinical pharmacology and drug development (1995) (0)
- Structural modifications of human CGRP and their effect on osteoclastic bone resorption (1987) (0)
- Transplantation Bone Disease Induced by Non-Steroid Immunosuppressants (2005) (0)
- Faculty Opinions recommendation of Metabolic consequences of gonadotropin-releasing hormone agonists vs orchiectomy: a randomized clinical study. (2019) (0)
- Editor's evaluation: Therapeutic downregulation of neuronal PAS domain 2 (Npas2) promotes surgical skin wound healing (2021) (0)
- Mechanisms regulating bone mass (2011) (0)
- Novel mechanisms of osteoclast regulation. (1991) (0)
- Editor's evaluation: Differences in pathways contributing to thyroid hormone effects on postnatal cartilage calcification versus secondary ossification center development (2022) (0)
- In Memoriam 2020 (2020) (0)
- Bone Loss and Body Composition Across The Menopausal Transition (2020) (0)
- Cellular Ionic Homeostatic Processes in Osteoclastic Bone Resorption (2020) (0)
- The Clinical, Genetic and Structural Basis of Congenital Adrenal Hyperplasia Due to 11β- Hydroxylase Deficiency: Results from the International Consortium on Rare Steroid Disorders (2017) (0)
- Chapter 23 Osteomalacia : A Cause of Bisphosphonate Failure (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mone Zaidi?
Mone Zaidi is affiliated with the following schools:
